Potency and Duration of Action of IV Steroids
For clinical practice, hydrocortisone has the shortest duration of action (biological half-life 8-12 hours), methylprednisolone has intermediate duration (12-36 hours), and dexamethasone has the longest duration (36-72 hours), with relative anti-inflammatory potencies of 1:5:25-30 respectively.
Relative Potencies
The three commonly used IV glucocorticoids differ substantially in their anti-inflammatory potency:
- Hydrocortisone: Baseline potency of 1 (reference standard) 1
- Methylprednisolone: 5 times more potent than hydrocortisone 1
- Dexamethasone: 25-30 times more potent than hydrocortisone 1
Critical conversion principle: When switching between agents, methylprednisolone 4 mg = hydrocortisone 20 mg = dexamethasone 0.75 mg in terms of anti-inflammatory effect 1
Duration of Action and Dosing Intervals
Hydrocortisone
- Biological half-life: 8-12 hours 1
- Plasma half-life: Approximately 90 minutes 2
- Recommended dosing interval: Every 4-6 hours when sustained high blood levels are needed 2
- Typical IV dose for stress/sepsis: 200-300 mg/day, given either as continuous infusion or as boluses every 6 hours 3
- Rationale for frequent dosing: The short 90-minute plasma half-life necessitates either continuous infusion or frequent bolus administration to maintain therapeutic levels 2
Methylprednisolone
- Biological half-life: 12-36 hours 1
- Typical dosing interval: Every 12-24 hours 3
- Standard pulse therapy: 500-1000 mg/day IV for 1-3 days for severe inflammatory conditions 3, 4
- For lupus nephritis: 250-500 mg/day for 3 consecutive days, or total dose 500-2500 mg depending on severity 3, 4
- For Behçet's syndrome: 1 g/day for up to 7 days 3
Dexamethasone
- Biological half-life: 36-72 hours 1
- Typical dosing interval: Once daily 5
- Standard dose for sepsis: 6 mg once daily 5
- Advantage: Longest duration allows once-daily dosing 5
- Disadvantage: Much longer half-life increases risk of adverse effects, particularly neurodevelopmental effects in neonates, and makes it unsuitable for physiologic replacement therapy 2
Clinical Implications by Indication
Sepsis and Septic Shock
- Hydrocortisone is preferred: 200-300 mg/day as continuous infusion or divided every 6 hours 3
- Continuous infusion is superior to intermittent boluses for maintaining physiologic cortisol concentrations 2
- Duration typically 7-14 days, or less if rapidly improving 3
Severe Autoimmune Disease (Lupus, Vasculitis)
- Methylprednisolone is preferred: 500-1000 mg/day for 3 consecutive days as pulse therapy 3, 4
- Follow with oral prednisone 0.3-0.5 mg/kg/day, rapidly tapered to ≤7.5 mg/day by 3-6 months 3
- The intermediate duration allows once or twice daily dosing while providing sustained immunosuppression 3
Acute Severe Asthma
- Hydrocortisone may be more effective: 200 mg every 4 hours showed shorter time to recovery compared to methylprednisolone 125 mg every 12 hours (median 30 vs 36 hours hospital stay, p=0.01) 6
- Alternative: Methylprednisolone, hydrocortisone, or dexamethasone at equivalent doses show similar efficacy in pediatric populations 7
COVID-19 ARDS
- Dexamethasone showed trend toward better outcomes: 6 mg once daily demonstrated better clinical status scores at 28 days compared to equivalent doses of methylprednisolone or hydrocortisone (p=0.003) 5
Common Pitfalls to Avoid
Do not assume plasma half-life equals duration of action: The biological effects persist far longer than plasma levels, particularly for methylprednisolone and dexamethasone 1
Do not use 1:1 conversion between methylprednisolone and prednisone: Methylprednisolone is 1.25 times more potent than prednisone 4
Do not stop corticosteroids abruptly after prolonged use: Inflammation may recur, especially with abrupt discontinuation 3. Patients receiving >14 days may require tapering and evaluation of hypothalamic-pituitary-adrenal axis function 3
Do not use dexamethasone for physiologic replacement: Its long half-life makes it unsuitable for mimicking natural cortisol rhythm and increases risk of over-replacement 2
Monitor for recurrence after discontinuation: Carefully observe all patients after stopping corticosteroids, as deterioration may occur requiring reinitiation 3
Adjust for liver disease: Cortisone and prednisone require hepatic conversion to active 11-beta-hydroxyl forms; this conversion may be impaired in liver disease 1